Extrusion of amyloid fibrils to the extracellular space in experimental mesangial al-amyloidosis: Transmission and scanning electron microscopy studies and correlation with renal biopsy observations

Ultrastructural Pathology

Volumn 38, Issue 2, 2014, Pages 104-115

  Teng, Jiamin ^a   Turbat Herrera, Elba A ^b   Herrera, Guillermo A ^a,c  

^a Department of Pathology ^*  (United States)

^b Departments of Pathology and ObGyn   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Amyloid; Light chains; Pathogenesis; Scanning electron microscopy; Transmission electron microscopy

Indexed keywords

AMYLOID;

AMYLOIDOSIS; ANIMAL; ARTICLE; BIOPSY; DISEASE MODEL; EXTRACELLULAR SPACE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; MESANGIUM CELL; METABOLISM; PATHOLOGY; RAT; SCANNING ELECTRON MICROSCOPY; SECRETION (PROCESS); TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

AMYLOID; AMYLOIDOSIS; ANIMALS; BIOPSY; DISEASE MODELS, ANIMAL; EXTRACELLULAR SPACE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MESANGIAL CELLS; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; RATS;

EID: 84896795309     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.3109/01913123.2013.861568     Document Type: Article

References (42)

1. Edelman GM, Gally JA. The nature of Bence Jones protein: Chemical similarities to polypeptide chains of myeloma globulins and normal gamma globulins. J Exp Med 1962; 116: 202-27.
2. Glenner GG, Ein D, Eanes ED, et al. Creation of "amyloid" fibrils from Bence-Jones proteins in-vitro. Science 1971;174: 712-14.
3. Solomon A, Frangione B, Franklin EC. Bence Jones proteins and light chains of immunoglobulins. Preferred association of the V lambda VI subgroup of human light chains with amyloidosis. J Clin Invest 1982;70: 453-60. (Pubitemid 12042646)
4. Comenzo RL, Zhang Martinez C, Osman K, Herrera GA. The tropism of organ involvement in primary systemic amyloidosis. Contributions of the Ig VL germline gene use and clonal plasma cell burden. Blood 2001;98: 714-20.
5. Solomon A, Weiss DT. Protein and host factors implicated in the pathogenesis of light chain amyloidosis (AL amyloidosis). Amyloid J Exp Clin Invest 1995;2: 269-79.
6. Solomon A, Weiss DT, Kattine AA. Nephrotoxic potential of Bence Jones proteins. N Engl J Med 1991;324: 1845-51.
7. Solomon A, Weiss DT, Schell M, et al. Transgenic mouse model of AA amyloidosis. Am J Pathol 1999;154: 1267-72. (Pubitemid 29169760)
8. Gise H, Christ H, Bohle A. Early glomerular lesions in amyloidosis. Virchows Arch [A] 1981;390: 259-72.
9. Schlondorff D. The glomerular mesangial cell: An expanding role for a specialized pericyte. FASEB J 1987;1: 272-81. (Pubitemid 18034353)
10. Herrera GA. Plasticity of mesangial cells: A basis for understanding pathological alterations. Ultrastruct Pathol 2006;30: 471-9. (Pubitemid 46018575)
11. Smetana H. The relation of the reticulo-endothelial system to the formation of amyloid. J Exp Med 1927;45: 619-32.
12. Shirahama T, Cohen AS. An analysis of the close relationship of lysosomes to early deposits of amyloid. Ultrastructural evidence in experimental mouse amyloidosis. Am J Pathol 1973;73: 97-114.
13. Shirahama T, Cohen AS. Intralysosomal formation of amyloid fibrils. Am J Pathol 1975;81: 101-16.
14. Shirahama T, Cohen AS. Lysosomal breakdown of amyloid fibrils by macrophages. Am J Pathol 1971;63: 463-86.
15. Shirahama T, Cohen AS. Fine structure of the glomerulus in human and experimental amyloidosis. Am J Pathol 1973; 73: 97-114.
16. Zucker-Franklin D, Franklin EC. Intracellular localization of human amyloid by fluorescence and electron microscopy. Am J Pathol 1970;59: 23-42.
17. Kluve-Beckerman B, Manaloor JJ, Liepnieks JJ. A pulsechase study tracking the conversion of macrophageendocytosed serum amyloid A into extracellular amyloid. Arthritis Rheum 2003;46: 1905-13. (Pubitemid 34774523)
18. Gueft G, Ghidoni JJ. The site of formation and ultrastructure of amyloid. Am J Pathol 1963;43: 837-54.
19. Linke RP, Zucker-Franklin D, Franklin EC. Morphologic, chemical, and immunologic studies of amyloid-like fibrils formed from Bence Jones proteins proteolysis. J Immunol 1973;111: 10-23.
20. Epstein WC, Tran M, Wood IS. Formation of "amyloid" fibrils in vitro by action of human kidney lysosomal enzymes on Bence Jones proteins. J Lab Clin Med 1974;84: 107-10.
21. Isaac J, Kerby JD, Russell WJ, et al. In-vitro modulation of AL-amyloid formation by human mesangial cells exposed to amyloidogenic light chains. Amyloid: Int J Exp Clin Invest 1998;5: 238-46. (Pubitemid 128690762)
22. Tagouri Y, Sanders PW, Picken MM, et al. In vitro AL-amyloid formation by rat and human mesangial cells. Lab Invest 1996;74: 290-302. (Pubitemid 26041030)
23. Russell WJ, Cardelli J, Harris E, et al. Monoclonal light chain-mesangial cells interactions: Early signaling events and subsequent pathologic effects. Lab Invest 2001;81: 689-703. (Pubitemid 32466532)
24. Teng J, Russell WJ, Gu X, et al. Different types of glomerulopathic light chains interact with mesangial cells using a common receptor but exhibit different intracellular trafficking patterns. Lab Invest 2004;84: 440-51. (Pubitemid 41656472)
25. Herrera GA, Russell WJ, Isaac J, et al. Glomerulopathic light chain-Mesangial cell interactions modulate in vitro extracellular matrix remodeling and reproduce mesangiopathic findings documented in vivo. Ultrastruct Pathol 1999;23: 107-26. (Pubitemid 29207181)
26. Teng J, Turbat-Herrera EA, Herrera GA. The role of translational research in advancing the understanding of the pathologenesis of light chain (LC)-mediated glomerulopathies. Pathol Int 2007;57: 398-412. (Pubitemid 46976407)
27. Keeling J, Herrera GA. Matrix metalloproteinases and mesangial remodeling in light chain-related glomerular damage. Kidney Int 2005;68: 1590-603. (Pubitemid 43169904)
28. Belloti V, Mangione P, Merlini G. Review: Immunoglobulin light chain amyloidosis-The archetype of structural and pathogenic variability. J Struct Biol 2000;130: 280-9.
29. Stevens FJ. Four structural risk factors identify most fibrilforming kappa light chains. Amyloid: Int J Exp Clin Invest 2000;7: 200-11.
30. Wall J, Schell M, Murphy C, et al. Thermodynamic instability of human-6 light chains: Correlation with fibrillogenicity. Biochemistry 1999;38: 14101-8.
31. Omtvedt LA, Bailey D, Renouf DV, et al. Glycosylation of immunoglobulin light chains associated with amyloidosis. Amyloid: Int J Exp Clin Invest 2000;7: 227-44.
32. Harper PA, Robinson JM, Hoover RL, et al. Improved methods for culturing rat glomerular cells. Kidney Int 1984; 26: 875-80. (Pubitemid 15197010)
33. Sanders PW, Herrera GA, Galla JH. Human Bence Jones protein toxicity in rat proximal tubule epithelium in vivo. Kidney Int 1987;32: 851-61. (Pubitemid 18015516)
34. Herrera GA, Sanders PW, Reddy BV, et al. Ultrastructural immunolabeling: A unique diagnostic tool in monoclonal light chain related renal diseases. Ultrastruct Pathol 1994;18: 401-16. (Pubitemid 24250257)
35. Walker PD. The renal biopsy. Arch Pathol Lab Med 2009;133: 181-8.
36. Wagroswska-Danilewicz M, Zeromski J. Immunofluorescent evaluation of renal biopsy: Current point of view. Pol J Pathol 2010;2: 83-8.
37. Cohen AS, Connors LH. The pathogenesis and biochemistry of amyloidosis. J Pathol 1987;151: 1-10. (Pubitemid 17029341)
38. Merlini G, Belloti V. Molecular mechanisms of amyloidosis. New Engl J Med 2003;349: 583-96. (Pubitemid 36951371)
39. Teng M, Yin J, Vidal R, et al. Towards understanding the structure-function relationship of human amyloid disease. Curr Drug Targets 2004;5: 159-71.
40. Herrera GA, Teng J, Turbat-Herrera EA. Scanning/transmission electron microscopy to study how amyloid fibrils are extruded into the matrix in renal mesangium. Amyloid J Protein Fold Dis 2010;17: 110.
41. Herrera GA, Turbat-Herrera EA, Teng J. AL-amyloidogenesis by mesangial cells: Insights from an in-vivo animal model (Abstract). J Am Soc Nephrol 2009;20: 566A.
42. Herrera GA, Teng J, Turbat-Herrera EA. Renal amyloidosis: Current views on pathogenesis and impact on diagnosis. In: Herrera GA, ed. Experimental models for renal diseases: pathogenesis and diagnosis. In contributions to nephrology series. Vol. 169 (Ronco C, ed). Karger Pub, 2011:232-44.